clinical use. The mechanisms of its toxic action remain unknown. The major objectives of this study were to characterize oxidative metabolites of physcion in vitro and in vivo and to determine the electrophilicity of the parent compound and its oxidative metabolites. Five oxidative metabolites (M1–M5) were detected in rat liver microsomal incubations after exposure to physcion, and the formation of the
Physcion(1,8-dihydroxy-3-methoxy-6-methyl-9,10-anthracenedione)是在何首乌(PMR)中发现的一种
生物活性成分,已被广泛用作中药。不幸的是,研究表明PMR在其临床使用期间具有肝毒性。其毒性作用的机制仍然未知。这项研究的主要目的是在体外和体内表征physion的氧化代谢产物,并确定母体化合物及其氧化代谢产物的亲电性。暴露于physion后在大鼠肝微粒体温育中检测到五种氧化代谢物(M1-M5),且代谢物的形成与
NADPH依赖。M1-
M4是单羟基化代谢物,M5是O-脱甲基化代谢物。一共三个N在以
NAC为诱捕剂强化的大鼠肝微粒体中观察到了-乙酰半胱
氨酸(
NAC)缀合物(M6-M8)。M6衍生自与
NAC分子缀合的
M4;M7和M8分别来自与
NAC分子加成的母体化合物physcion。服用physcion的大鼠尿液中也观察到了M1-M8。HLM